An L3 adjustment on a Medicare electronic remittance advice (the ERA, sometimes called the explanation of benefits, or EOB) reports money withheld from a payment under the description "Penalty," and it can be mistaken for a routine accounting entry. For laboratories and other Medicare providers, a run of L3 withholds can be the first visible sign that payments have been suspended, sometimes at the request of a Unified Program Integrity Contractor (UPIC). The window to respond to a suspension is short, and the decision on that response is unappealable, so what the provider does in the first days after L3 withholds appear can shape the outcome of the matter.
What an L3 Code Means
Providers often refer to these entries as "L3 denials," although L3 is a provider-level adjustment code in the ERA (the 835 file) rather than a claim denial. Because the adjustment applies to the payment as a whole, individual claims can show as processed while the payment itself is withheld. In its crosswalk of provider-level adjustment codes, the Centers for Medicare & Medicaid Services (CMS) mapped a wide range of full and partial payment holds to L3, including holds for fraud and abuse, holds made at CMS's request, administrative freezes, bankruptcy and unfiled cost reports. The same code also reports the release of a hold. Note any reference number reported with each L3 line and ask the Medicare Administrative Contractor (MAC) what the hold is for. Until the MAC answers, a pattern of L3 withholds should be treated as a possible payment suspension.
The Legal Basis for a Medicare Payment Suspension
Under 42 C.F.R. § 405.371(a)(1), CMS or a Medicare contractor may suspend payments, in whole or in part, on reliable information that an overpayment exists or that payments may be incorrect, even while more information is needed. Where CMS, after consulting the Department of Health and Human Services (HHS) Office of Inspector General (OIG) and, as appropriate, the Department of Justice (DOJ), determines that a credible allegation of fraud exists, payments may be suspended in whole or in part unless there is good cause not to (§ 405.371(a)(2)). An allegation is credible when it has "indicia of reliability," and the regulation names verified hotline tips, claims data mining and patterns found in audits and investigations as sources (§ 405.370). Both standards permit a suspension before any overpayment or fraud has been established.
A suspension can take effect without prior notice when CMS decides prior notice would be inappropriate in a fraud case, when notice would harm the Medicare Trust Funds, or when the provider has failed to submit information the contractor requested to determine the amounts due (§ 405.372(a)(2)-(4)). In those cases a provider can see the withholds on its remittance before it receives any letter. Suspended funds are applied first to any overpayment determined, including interest, then to other debts owed to CMS or HHS, and only the remainder is released (§ 405.372(e)).
A suspension based on an overpayment concern is limited to 180 days from the date it begins, with a one-time extension of up to 180 more days if CMS approves a written request (§ 405.372(d)). A fraud-based suspension falls outside those limits. CMS re-evaluates that suspension every 180 days and asks law enforcement to certify that the investigation continues. After 18 months without resolution, good cause to end it is deemed to exist, although CMS may extend it if the matter is before OIG for administrative action or DOJ requests continuation in writing (§ 405.371(b)). State Medicaid agencies operate under their own rule: on a credible allegation of fraud they must suspend Medicaid payments unless good cause exists (42 C.F.R. § 455.23), and a Medicaid suspension can in turn support a Medicare suspension (§ 405.371(a)(4)).
A suspension can begin before any overpayment or fraud has been established, and the withholds can appear on the remittance before any letter arrives.
The Rebuttal Statement
The Medicare claims appeal process offers no route to challenge a suspension. The provider's remedy is a rebuttal statement explaining why the suspension should not take effect or should be removed (§ 405.372(b)). Where prior notice is given, the provider ordinarily has at least 15 days from notification, and the contractor may set a shorter or longer period for cause (§ 405.374). Where the suspension takes effect without prior notice, the regulation sets no fixed period, and the deadline is the one stated in the notice the contractor sends. The suspension proceeds on the date in the notice, or continues if already in effect, while the rebuttal is under review. CMS or the contractor must consider the statement within 15 days of receipt and send written findings (in a fraud-based suspension, CMS makes the decision), and that determination "is not an initial determination and is not appealable" (§ 405.375). Claim denials and any overpayment determination that follow carry their own appeal rights.
Because those findings must address the conditions the suspension rests on (§ 405.375(b)), the statement should answer each ground given in the notice, point by point, with the provider's own records: test orders, requisitions, medical necessity documentation and billing data. In a fraud-based suspension, OIG and possibly DOJ are already involved, and the rebuttal can become evidence.
Steps to Take When L3 Withholds Appear
Reconcile recent remittances to establish when the withholds began and how much has been held. Ask the MAC whether a suspension is in place and obtain the notice, since it sets the rebuttal deadline. Preserve every relevant record exactly as it exists. Answer each records request completely and on time, since unanswered requests lead to denied claims. Route those responses and any contact with investigators through counsel.
Early Engagement of Counsel
It is critical that laboratories and other providers promptly retain experienced healthcare defense counsel upon seeing unexplained L3 withholds or receiving a suspension notice, records request or other government inquiry. Early legal intervention can protect the provider's rights, ensure appropriate responses to the contractor, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with investigators on the provider's behalf. Delaying representation can significantly affect the outcome of a matter and expose the provider to unnecessary risk.
How Health Law Alliance Can Help
Health Law Alliance defends laboratories and other healthcare providers in Medicare payment suspensions, UPIC audits, overpayment demands and the investigations that follow them. Our founding partner is a former federal prosecutor who later served as Chief Compliance Officer at UnitedHealth Group, a background that informs our assessment of how a contractor builds a suspension and where it can be challenged. If your laboratory or practice has received a suspension notice or is seeing L3 withholds, call (800) 345 - 4125 or contact us for a free, confidential consultation.
